A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2002
10/22/2002	US6468964 Administering to human or animal active agent capable of preventing or controlling acid and endotoxin accumulation in gastrointestinal tract, selected from antibiotics, enzymes, clays, probiotics, compounds which slow rate of passage
10/22/2002	US6468798 Liposome-nucleic acid complexes are prepared then delivered via aerosol to the lung airway; for transforming pulmonary cells and treating lung diseases
10/22/2002	US6468791 Chromosone 1 gene and gene products related to Alzheimer's disease
10/22/2002	US6468782 Cells are cultured or incubated under conditions sufficient to induce intracellular trehalose, suspended in stabilizing solution and dried to form a solid glass; storage stablility
10/22/2002	US6468756 Methods of identifying compounds that bind to SNORF25 receptors
10/22/2002	US6468737 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders
10/22/2002	US6468546 Compositions and methods for therapy and diagnosis of ovarian cancer
10/22/2002	US6468545 Helicobacter pylori catalase.
10/22/2002	US6468544 Genetically engineered influenza a virus with an interferon-inducing phenotype wherein said virus comprises a viral genome wherein the complete ns1 coding sequences have been deleted (delns1).
10/22/2002	US6468540 Immunotherapeutic stress protein-peptide complexes against cancer
10/22/2002	US6468539 Protein targeting into HIV virions based on HIV-1 VPR fusion molecules
10/22/2002	US6468537 Nucleosome histone protein
10/22/2002	US6468534 Methods for obtaining transfer factor from avian sources, compositions including avian-generated transfer factor, and methods of use
10/22/2002	US6468533 Polyclonal or monoclonal antibody that inhibits high mobility group 1 protein mediated activation of inflammatory cytokine cascade; sepsis
10/22/2002	US6468530 Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype
10/22/2002	US6468529 Fab fragment of a monoclonal antibody; binds to c-met receptor; cancer treatment
10/22/2002	US6468526 For therapy of vaginal and gastrointestinal infections
10/22/2002	CA2246754C Cochleate delivery vehicles
10/22/2002	CA2216601C Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies
10/22/2002	CA2188447C Recombinant poxviruses with foreign polynucleotides in essential regions
10/22/2002	CA2185712C Enhanced virus-mediated dna transfer
10/22/2002	CA2147989C Enhancement of xenograft tolerance and porcine cytokines therefor
10/22/2002	CA2040544C Actinobacillus pleuropneumoniae subunit vaccine
10/17/2002	WO2002082091A2 Method for identification of proteins from intracellular bacteria
10/17/2002	WO2002082077A2 Production of polyclonal monospecific antibodies against upar variants del4, del5 and del4+5, and the use thereof for diagnostic and therapeutical purposes
10/17/2002	WO2002082076A2 Renal cell carcinoma tumor markers
10/17/2002	WO2002082075A2 Method for detecting chronic dementia diseases, and corresponding peptides and detection reagents
10/17/2002	WO2002082044A2 Method of imaging cell death in vivo
10/17/2002	WO2002082041A2 Production and use of novel peptide-based agents for use with bi-specific antibodies
10/17/2002	WO2002081754A1 Nucleic acid vaccines for prevention of flavivirus infection
10/17/2002	WO2002081747A1 Method of examining steroid responsiveness
10/17/2002	WO2002081745A2 Genes involved in osteogenesis, and methods of use
10/17/2002	WO2002081715A1 A transgenic non-human animal having a disruption of at least one allele to the ceacam1 gene and method of making same
10/17/2002	WO2002081712A2 Artificial chromosomes comprising ehv sequences
10/17/2002	WO2002081709A2 Modified hpv e6 and e7 genes and proteins useful for vaccination
10/17/2002	WO2002081706A2 Regulation of human phosphatase-like protein
10/17/2002	WO2002081704A2 Regulation of human protein kinase-like protein
10/17/2002	WO2002081689A1 Regulation of human cyclic nucleotide-gated channel ocnc2 subunit
10/17/2002	WO2002081665A2 Implantation serine proteinases
10/17/2002	WO2002081661A2 Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides
10/17/2002	WO2002081653A2 An animal model for enteric pathogens
10/17/2002	WO2002081649A2 ErbB INTERFACE PEPTIDOMIMETICS AND METHODS OF USE THEREOF
10/17/2002	WO2002081646A2 Epitope sequences
10/17/2002	WO2002081625A2 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
10/17/2002	WO2002081621A2 Vaccine against the nile fever virus
10/17/2002	WO2002081522A1 Anti-osteopontin antibody and use thereof
10/17/2002	WO2002081512A1 Dust mite der p1 cd8+ t-cell epitopes and uses thereof
10/17/2002	WO2002081511A1 Neurovirulent strain of the west nile virus and applications thereof
10/17/2002	WO2002081508A2 Use of cd25 binding molecules in steroid-resistant patients
10/17/2002	WO2002081504A2 Multimerization of hiv-1 vif protein as a therapeutic target
10/17/2002	WO2002081496A2 Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours
10/17/2002	WO2002081413A2 One dimensional unichemo protection (ucp) in organic synthesis
10/17/2002	WO2002080987A1 Anti-cd19 immunotoxins
10/17/2002	WO2002080982A2 Nucleic acid mucosal immunization
10/17/2002	WO2002080981A2 Polynucleotide binding complexes comprising sterols and saponins
10/17/2002	WO2002080972A1 Association of a tumor antigen and a system for delivering a cytokine or a chemokine for cancer immunotherapy purposes
10/17/2002	WO2002080967A1 Method to inhibit airway hyperresponsiveness using aerosolized t cell receptor antibodies
10/17/2002	WO2002080966A2 Method for producing a vaccine containing autologous antibodies
10/17/2002	WO2002080965A2 Vaccine composition
10/17/2002	WO2002080963A1 Methods of mhc class ii epitope mapping, detection of autoimmune t cells and antigens, and autoimmune treatment
10/17/2002	WO2002080954A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
10/17/2002	WO2002080948A1 Compositions and methods for treating inflammation and related conditions
10/17/2002	WO2002080851A2 Chimeric vaccines
10/17/2002	WO2002080840A2 Immunity adjuvant containing a complexed metal cation and vaccine containing same
10/17/2002	WO2002080682A1 Improved anti-inflammatory herbal composition and method of use
10/17/2002	WO2002080648A2 Mucosal boosting following parenteral priming
10/17/2002	WO2002060924A3 Identification and applications of porcine reproductive and respiratory syndrome virus host susceptibility factor(s) for improved swine breeding and development of a non-simian recombinant cell line for propagation of the virus and a target for a novel class of antiviral compounds
10/17/2002	WO2002044205A3 Peptides from ag85 of mycobacterium and uses thereof
10/17/2002	WO2002043757A3 Medicament for preventing or treating tumors caused by human papilloma virus type 18
10/17/2002	WO2002043699A3 Preparation of large liposomes by infusion into peg
10/17/2002	WO2002042292A3 Indol derivative and their use as inhibitors of p38 kinase
10/17/2002	WO2002038607A3 A 'bach' g protein coupled receptor polypeptide and polynucleotide encoding this receptor
10/17/2002	WO2002036733A9 Cd36 as a heat shock protein receptor and uses thereof
10/17/2002	WO2002036108A3 Use of 20-hete synthesizing enzyme inhibitors as therapy for cerebral vascular diseases
10/17/2002	WO2002028372A3 Systemic delivery of compounds through non-invasive bladder administration
10/17/2002	WO2002015920A3 Treatment of hyperproliferative diseases
10/17/2002	WO2002009645A3 Intercellular transport protein linked to an antigen as a molecular vaccine
10/17/2002	WO2001074404A3 Compositions containing genetically modified lung cancer cells expressing a tgf-beta inhibitor
10/17/2002	WO2001060847A9 Avirulent, immunogenic flavivirus chimeras
10/17/2002	WO2001060391A9 A universal vaccine and method for treating cancer employing telomerase reverse transcriptase
10/17/2002	WO2001058922A9 Method and compositions for treating hepatocellular cancer
10/17/2002	WO2001054723A9 Therapeutic method for reducing angiogenesis
10/17/2002	WO2001054712A9 Compositions and methods for the early diagnosis of ovarian cancer
10/17/2002	WO2001052878A9 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy
10/17/2002	WO2001042423A9 Compositions and methods for detecting stress-inducible proteins
10/17/2002	US20020152485 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
10/17/2002	US20020151707 Soluble, fused major histocompatability complexes and peptide complexes; glutamate decarboxylase; autoimmunity
10/17/2002	US20020151706 Antiinflammatory agents
10/17/2002	US20020151695 Transforming growth factor-beta-related molecules and uses thereof
10/17/2002	US20020151691 Class II transactivators (CIITA); major histocompatability complex; gene expression inhibition; cloning; vaccines; transcriptional promoter activity
10/17/2002	US20020151689 Method of killing target cells in harvested cell populations with one or more immuno-toxins
10/17/2002	US20020151688 Generating virally deactivated immunoglobulin; obtain mixture containing immunoglobulin, suspend in carbohydrate solution, reduce impurities, apply column, filter, recover efluent, inactivate with virus, preciptate and recover immunoglobulin
10/17/2002	US20020151683 Peptide for use in the prevention and treatment of viral diseases
10/17/2002	US20020151682 Biological products
10/17/2002	US20020151678 Prophylaxis and therapy of acquired immunodeficiency syndrome
10/17/2002	US20020151677 Replikins and methods of identifying replikin-containing sequences
10/17/2002	US20020151598 Bronchodilating compositions and methods
10/17/2002	US20020151597 Formoterol, or a derivative; long term storage stability
10/17/2002	US20020151517 Administering to the mammal nucleosomes(a complex of DNA and histones) that elicit the production of antinuclear autoantibodies sufficient to inhibit neoplastic cell growth
10/17/2002	US20020151514 Genes associated with mechanical stress, expression products therefrom, and uses thereof

1 ... 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 ... 1823